Department of Endocrinology, The First Affiliated Hospital, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
J Diabetes. 2020 Jan;12(1):66-76. doi: 10.1111/1753-0407.12963. Epub 2019 Aug 6.
Because there has been no quality improvement initiatives targeting patients with type 2 diabetes (T2D) receiving basal insulin therapy, this study evaluated the effectiveness of physician-targeted education for optimizing glycemic management in these patients in China.
This multicenter open-label observational study conducted across China had a baseline sample survey, followed by a 6-month education program, and ended with a post-education sample survey. Education based on T2D treatment guidelines was given at Months 1 and 3, and was reinforced by self-audit every month. Each hospital enrolled 100 patients with T2D receiving basal insulin at both the baseline and post-education survey. The primary outcome was the proportion of hospitals meeting individual improvement goals. The goal setting was based on the proportion of patients achieving HbA1c <7.0% in each hospital at the time of the baseline survey.
Overall, the individual improvement goal was achieved by 35 centers (49%). Hospitals with poor glycemic management at the baseline survey had higher possibility to improve at post-education survey. Two large sample surveys at baseline and post-education showed improved glucose management among these hospitals. A higher proportion of patients achieved HbA1c <7.0% in the post-education survey (27.2% vs 36.5%; P < 0.001) with reduced HbA1c levels (8.10% vs 7.72%; P < 0.001). Questionnaires from 723 physicians showed that confidence and practice of basal insulin use were significantly improved.
Physician-targeted education improved glycemic management of patients with T2D in 71 hospitals in China, and was more effective at hospitals with poor glycemic management at the baseline survey.
由于目前尚无针对接受基础胰岛素治疗的 2 型糖尿病(T2D)患者的质量改进措施,本研究评估了针对医生的教育对优化这些患者血糖管理的有效性。
本研究是在中国开展的一项多中心开放标签观察性研究,包括基线样本调查、6 个月的教育项目以及教育后样本调查。在第 1 个月和第 3 个月根据 T2D 治疗指南进行教育,并每月进行自我审核以加强教育。每家医院在基线和教育后调查中各纳入 100 例接受基础胰岛素治疗的 T2D 患者。主要结局是符合个别改善目标的医院比例。目标设定基于基线调查时每家医院达到 HbA1c<7.0%的患者比例。
总体而言,有 35 家医院(49%)达到了个别改善目标。基线调查时血糖管理较差的医院在教育后调查中更有可能改善。在基线和教育后进行的两次大型样本调查显示,这些医院的血糖管理得到改善。在教育后调查中,更多的患者达到了 HbA1c<7.0%(27.2%比 36.5%;P<0.001),且 HbA1c 水平降低(8.10%比 7.72%;P<0.001)。对 723 名医生的问卷调查显示,他们使用基础胰岛素的信心和实践显著提高。
针对医生的教育改善了中国 71 家医院 T2D 患者的血糖管理,对基线调查时血糖管理较差的医院更有效。